Table 4. Incidence (per 100 person-years) of Major Hemorrhage by CYP4F2 genotype.
CYP4F2 genotype | N | Events | FU years |
Incidence | Incidence rate ratio |
P Value |
---|---|---|---|---|---|---|
All | ||||||
*1/*1 | 784 | 92 | 1099.5 | 8.37 (6.75 -10.26) | Reference | — |
*1/*3 | 390 | 44 | 554.6 | 7.93 (5.76-10.65) | 0.95 (0.66 -13.53) | 0.85 |
*3/*3 | 64 | 4 | 107.5 | 3.72 (1.00-9.53) | 0.44 (0.14-1.10) | 0.09 |
European Americans | ||||||
*1/*1 | 340 | 36 | 504.0 | 7.14 (5.00-9.89) | Reference | — |
*1/*3 | 305 | 35 | 438.2 | 7.99 (5.56-11.11) | 1.12 (0.70-1.79) | 0.64 |
*3/*3 | 62 | 4 | 103.8 | 3.85 (1.04-9.87) | 0.54 (0.16-1.40) | 0.24 |
African Americans | ||||||
*1/*1 | 444 | 56 | 595.5 | 9.40 (7.10-12.21) | Reference | |
*1/*3 | 85 | 9 | 116.4 | 7.73 (3.53-14.68) | 0.82 (0.38-1.61) | 0.61 |
*3/*3 | 2 | 0 | 3.7 | — | — | — |
| ||||||
CYP4F2 genotype (*1/*1 or *1/*3 versus *3/*3) | ||||||
| ||||||
All | ||||||
*1/*1 or *1/*3 | 1174 | 136 | 1654.1 | 8.22 (6.89 -9.73) | Reference | — |
*3/*3 | 64 | 4 | 107.5 | 3.72 (1.00-9.53) | 0.45 (0.14-1.11) | 0.09 |
European Americans | ||||||
*1/*1 or *1/*3 | 645 | 71 | 942.2 | 7.54 (5.89-9.51) | Reference | — |
*3/*3 | 62 | 4 | 103.8 | 3.85 (1.04-9.87) | 0.51 (0.16-1.28) | 0.22 |
African Americans | ||||||
*1/*1 or *1/*3 | 529 | 65 | 711.9 | 9.13 (7.10-11.56) | — | — |
*3/*3 | 2 | 0 | 3.7 | — | — | — |
| ||||||
CYP4F2 genotype (*1/*1 versus *1/*3 or *3/*3) | ||||||
| ||||||
All | ||||||
*1/*1 | 784 | 92 | 1099.5 | 8.37 (6.75 -10.26) | Reference | — |
*1/*3 or *3/*3 | 454 | 48 | 662.1 | 7.25 (5.35-9.61) | 0.87 (0.61-1.22) | 0.42 |
European Americans | ||||||
*1/*1 | 340 | 36 | 504.0 | 7.14 (5.00-9.89) | Reference | — |
*1/*3 or *3/*3 | 367 | 39 | 542.0 | 7.20 (5.12-9.84) | 1.01 (0.64-1.59) | 0.98 |
African Americans | ||||||
*1/*1 | 444 | 56 | 595.5 | 9.40 (7.10-12.21) | Reference | — |
*1/*3 or *3/*3 | 87 | 9 | 120.1 | 7.49 (3.42-14.23) | 0.80 (0.37-1.56) | 0.55 |
FU years: Follow-up years